Nagaraj Nagathihalli
Last active: 12/19/2014

  1. Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. Nagathihalli NS, Beesetty Y, Lee W, Washington MK, Chen X, Lockhart AC, Merchant NB (2014) Cancer Res 74(7): 2062-72
    › Primary publication · 24520077 (PubMed) · PMC3975694 (PubMed Central)
  2. Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells. Castellanos JA, Merchant NB, Nagathihalli NS (2013) Onco Targets Ther : 1261-7
    › Primary publication · 24049451 (PubMed) · PMC3775701 (PubMed Central)
  3. Src-mediated regulation of E-cadherin and EMT in pancreatic cancer. Nagathihalli NS, Merchant NB (2012) Front Biosci (Landmark Ed) : 2059-69
    › Primary publication · 22652764 (PubMed)
  4. Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin. Nagathihalli NS, Massion PP, Gonzalez AL, Lu P, Datta PK (2012) Mol Cancer Ther 11(11): 2362-72
    › Primary publication · 22933707 (PubMed) · PMC3969334 (PubMed Central)
  5. Smoking attenuates transforming growth factor-β-mediated tumor suppression function through downregulation of Smad3 in lung cancer. Samanta D, Gonzalez AL, Nagathihalli N, Ye F, Carbone DP, Datta PK (2012) Cancer Prev Res (Phila) 5(3): 453-63
    › Primary publication · 22232600 (PubMed) · PMC4299594 (PubMed Central)
  6. Translational research in gastrointestinal oncology: a focus on signaling pathways in pancreas cancer. Nagathihalli N (2011) Gastrointest Cancer Res 4(5-6): 197-8
    › Primary publication · 22295136 (PubMed) · PMC3269147 (PubMed Central)
  7. RAD51 as a potential biomarker and therapeutic target for pancreatic cancer. Nagathihalli NS, Nagaraju G (2011) Biochim Biophys Acta 1816(2): 209-18
    › Primary publication · 21807066 (PubMed)
  8. Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth. Nagaraj NS, Washington MK, Merchant NB (2011) Clin Cancer Res 17(3): 483-93
    › Primary publication · 21266529 (PubMed) · PMC3079196 (PubMed Central)
  9. Using genomics to develop novel antibacterial therapeutics. Nagaraj NS, Singh OV (2010) Crit Rev Microbiol 36(4): 340-8
    › Primary publication · 20670176 (PubMed)
  10. Targeting the transforming growth factor-beta signaling pathway in human cancer. Nagaraj NS, Datta PK (2010) Expert Opin Investig Drugs 19(1): 77-91
    › Primary publication · 20001556 (PubMed) · PMC2796203 (PubMed Central)